Sign Up Today and Learn More About PRISM BioLab Stock
Invest in or calculate the value of your shares in PRISM BioLab or other pre-IPO companies through EquityZen's platform.
PRISM BioLab Stock (PRIB)
PRISM develop therapeutic drugs that cure these intractable diseases using our unique peptide mimic technology.
About PRISM BioLab Stock
Founded
2006
Industries
Software, Artificial Intelligence, Data and Analytics
PRISM BioLab Press Mentions
Stay in the know about the latest news on PRISM BioLab
PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Protein-Protein Interaction Targets
en • Apr 14, 2025
PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Protein-Protein Interaction Targets
prnewswire • Apr 14, 2025
PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Protein-Protein Interaction Targets
morningstar • Apr 14, 2025
Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement
pharmafile • May 24, 2024
PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono
au • May 04, 2024
PRISM BioLab Management
Leadership team at PRISM BioLab
Outside Director
Morita Kohei
Part-time auditor
Tajima Teruhisa
Join now and verify your accreditation status to gain access to:
- PRISM BioLab Current Valuation
- PRISM BioLab Stock Price
- PRISM BioLab Management
- Available deals in PRISM BioLab and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- PRISM BioLab Cap Table and Funding History by Share Class and Liquidity Preferences
- PRISM BioLab Revenue and Financials
- PRISM BioLab Highlights
- PRISM BioLab Business Model
- PRISM BioLab Risk Factors
- PRISM BioLab Research Report from SACRA Research
Trading PRISM BioLab Stock
How to invest in PRISM BioLab stock?
Accredited investors can buy pre-IPO stock in companies like PRISM BioLab through EquityZen funds. These investments are made available by existing PRISM BioLab shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell PRISM BioLab stock?
Shareholders can sell their PRISM BioLab stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
